The methionine market remains weak, while lysine, threonine, tryptophan and valine prices appear to be bottoming at historically low levels. Anti-dumping measures on Chinese lysine and expected capacity additions are shaping regional dynamics, and cautious buyers are limiting forward purchases.
Persistent oversupply and new capacity keep amino acid prices depressed, which lowers the cost of synthetic amino acids in compound feed. Stabilisation at low levels suggests limited further downside, but no meaningful recovery is expected until capacity growth slows.
Not enough comparable past events yet for a historical read.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.